forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Market Size to Hit USD 212.73 Billion by 2035 GLP-1 Analogues Market Size, Share

However, there are some rare but serious risks, including pancreatitis and gallbladder issues

Interestingly, knockdown of RIPK1 exacerbated ZEA-induced toxicity but did not diminish the protective effect of scutellarin, implying potential pathway redundancy or alternative mechanisms of action

Our results suggest that thyroid cancer risk should be considered with GLP-1 receptor agonists, particularly in patients treated for 1 to 3 years, Jean-Luc Faillie, MD, PhD , professor and head of the department of medical pharmacology and toxicology at Montpellier University Hospital and University of Montpellier in France, and colleagues wrote

2024 [cited 2025 December 20]